6533b830fe1ef96bd12978b5
RESEARCH PRODUCT
TCT-664 Twelve-Month Clinical Outcomes Comparing Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Coronary Stents in Patients With De Novo Native Coronary Artery Lesions: The meriT-V Randomized Trial
Elvin KedhiSuneel TalwarFarzin Fath-ordoubadiPetr KalaLuc JanssensRicardo CostaAndrejs ĒRglisSasko KedevRoberto BotelhoMónica MasottiAlexander IjsselmuidenOta HlinomazSripal BangaloreAlexandre AbizaidJacques J. KoolenPedro A. LemosKrzysztof Milewskisubject
medicine.medical_specialtyEverolimusbusiness.industrymedicine.medical_treatmentStentequipment and suppliesBiodegradable polymer3. Good healthlaw.inventionSurgerysurgical procedures operativemedicine.anatomical_structureRandomized controlled triallawSirolimusCoronary stentDurable polymermedicinecardiovascular diseasesCardiology and Cardiovascular Medicinebusinessmedicine.drugArterydescription
The aim of this study is to compare the safety and efficacy of the biodegradable polymer coated sirolimus-eluting coronary stent (SES, BioMime™, Meril Life Sciences, India) with durable polymer coated everolimus-eluting coronary stent (EES, XIENCE family, Abbott Vascular, California, USA) in de
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2018-09-01 | Journal of the American College of Cardiology |